GlaxoSmithKline Invests $300 Million In 23andMe.
July 26, 2018
In what NBC News (7/25, Fox) calls “the biggest partnership yet” for the “increasingly popular home genetic testing market,” GlaxoSmithKline invested $300 million in 23andMe and reached a four-year deal “that gives Glaxo exclusive rights to collaborate w...